About Epigenica
Epigenica is a company based in Stockholm (Sweden) founded in 2020 by Simon Alsatian and Mohamad Takwa.. Epigenica has raised $2.2 million across 2 funding rounds from investors including European Union, Almi and Leksell Social Ventures. Epigenica offers products and services including EpiFinder Platform and EpiFinder Genome Kit. Epigenica operates in a competitive market with competitors including Chroma Medicine, FOXO Technologies, Reaction Biology, Inherent Biosciences and Chronomics, among others.
- Headquarter Stockholm, Sweden
- Founders Simon Alsatian, Mohamad Takwa
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Epigenica Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.2 M (USD)
in 2 rounds
-
Latest Funding Round
$2.2 M (USD), Seed
Jun 30, 2025
-
Investors
European Union
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epigenica
Epigenica offers a comprehensive portfolio of products and services, including EpiFinder Platform and EpiFinder Genome Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-throughput technology for multiplexed epigenetic profiling and research.
Commercial kit for genome-wide epigenomic analysis in multiple samples.
Unlock access to complete
Unlock access to complete
Funding Insights of Epigenica
Epigenica has successfully raised a total of $2.2M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.2 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $2.2M
-
First Round
First Round
(01 Jul 2022)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Seed - Epigenica | Valuation | Voima Ventures | |
| Jul, 2022 | Amount | Grant - Epigenica | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Epigenica
Epigenica has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Almi and Leksell Social Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding is provided for deep tech ventures in Nordics.
|
Founded Year | Domain | Location | |
|
Navigare Ventures is focused on early-stage science-driven investments.
|
Founded Year | Domain | Location | |
|
Impact investments are focused on by this private equity firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Epigenica
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Epigenica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epigenica Comparisons
Competitors of Epigenica
Epigenica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chroma Medicine, FOXO Technologies, Reaction Biology, Inherent Biosciences and Chronomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Epigenetic editing platform is developed for genomic medicines.
|
|
| domain | founded_year | HQ Location |
Epigenetic biomarkers are discovered and developed via AI platforms.
|
|
| domain | founded_year | HQ Location |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| domain | founded_year | HQ Location |
Epigenetic diagnostics and therapeutics for complex diseases are developed.
|
|
| domain | founded_year | HQ Location |
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
|
|
| domain | founded_year | HQ Location |
Epigenetic kits, reagents, and assays are supplied for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Epigenica
Frequently Asked Questions about Epigenica
When was Epigenica founded?
Epigenica was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Epigenica located?
Epigenica is headquartered in Stockholm, Sweden.
Who is the current CEO of Epigenica?
Mohamad Takwa is the current CEO of Epigenica. They have also founded this company.
Is Epigenica a funded company?
Epigenica is a funded company, having raised a total of $2.2M across 2 funding rounds to date. The company's 1st funding round was a Grant of $125.02K, raised on Jul 01, 2022.
What does Epigenica do?
Provider of solutions for the analysis of genomic data. The platform is offering tools, EpiQure, for testing epigenetic drug efficacy and toxicity screening in real-life pilots, EpiFinder, for large-scale biomarker discovery for disease diagnosis and prognosis, and EpIVD, which helps in lowering the cost of epigenetic diagnostics.
Who are the top competitors of Epigenica?
Epigenica's top competitors include Chroma Medicine, FOXO Technologies and EpiCypher.
What products or services does Epigenica offer?
Epigenica offers EpiFinder Platform and EpiFinder Genome Kit.
Who are Epigenica's investors?
Epigenica has 5 investors. Key investors include European Union, Almi, Leksell Social Ventures, Voima Ventures, and Navigare Ventures.